Identification of SMURF1 as a possible target for 7q21.3‐22.1 amplification detected in a pancreatic cancer cell line by in‐house array‐based comparative genomic hybridization

Pancreatic cancer (PC) cell lines provide a useful starting point for the discovery and functional analysis of genes driving the genesis and progression of this lethal cancer. To increase our understanding of the gene copy number changes in pancreatic carcinomas and to identify key amplification and deletion targets, we applied genome‐wide array‐based comparative genomic hybridization using in‐house array (MCG Cancer Array‐800) to 24 PC cell lines. Overall, the analyses revealed high genomic complexity, with several copy number changes detected in each line. Homozygous deletions (log2ratio < –2) of eight genes (clones) were seen in 14 of the 24 cell lines, whereas high‐level amplifications (log2ratio > 2) of 10 genes (clones) were detected in seven lines. Among them, we focused on high‐level amplification at 7q22.1, because target genes for this alteration remain unknown. Through precise mapping of the altered region by fluorescence in situ hybridization, determination of the expression status of genes located within those regions, and functional analysis using knockdown of the gene expression or the ectopic overexpression approach in PC cell lines, as well as immunohistochemical analyses of candidates in primary tumors of PC, we successfully identified SMURF1 as having the greatest potential as a 7q21.3‐22.1 amplification target. SMURF1 may work as a growth‐promoting gene in PC through overexpression and might be a good candidate as a therapeutic target. Our results suggest that array‐based comparative genomic hybridization analysis combined with further genetic and functional examinations is a useful approach for identifying novel tumor‐associated genes involved in the pathogenesis of this lethal disease. (Cancer Sci 2008; 99: 986–994)

[1]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[2]  C. Chelala,et al.  Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays , 2008, Oncogene.

[3]  S. Hirohashi,et al.  Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. , 2007, Cancer research.

[4]  S. Hirohashi,et al.  Genome‐wide array‐based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome , 2007, Cancer science.

[5]  J. Inazawa,et al.  A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity , 2007, Oncogene.

[6]  K. Garber.  New insights into oncogene addiction found. , 2007, Journal of the National Cancer Institute.

[7]  Erik Sahai,et al.  Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility , 2007, The Journal of cell biology.

[8]  M. McMahon,et al.  Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines , 2005, Genes, chromosomes & cancer.

[9]  R. Hruban,et al.  Genome-wide aberrations in pancreatic adenocarcinoma. , 2005, Cancer genetics and cytogenetics.

[10]  K. Miyazono,et al.  Degradation of the Tumor Suppressor Smad4 by WW and HECT Domain Ubiquitin Ligases* , 2005, Journal of Biological Chemistry.

[11]  Robert Tibshirani,et al.  Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. , 2005, Neoplasia.

[12]  S. Hirohashi,et al.  Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers. , 2005, Human molecular genetics.

[13]  Hidetaka Mochizuki,et al.  Screening of DNA copy‐number aberrations in gastric cancer cell lines by array‐based comparative genomic hybridization , 2005, Cancer science.

[14]  Sampsa Hautaniemi,et al.  High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer. , 2004, Neoplasia.

[15]  J. Inazawa,et al.  Comparative genomic hybridization (CGH)‐arrays pave the way for identification of novel cancer‐related genes , 2004, Cancer science.

[16]  Hans A. Kestler,et al.  Genomic DNA-Chip Hybridization Reveals a Higher Incidence of Genomic Amplifications in Pancreatic Cancer than Conventional Comparative Genomic Hybridization and Leads to the Identification of Novel Candidate Genes , 2004, Cancer Research.

[17]  L. Chin,et al.  High-resolution characterization of the pancreatic adenocarcinoma genome , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Chin,et al.  Frequent Silencing of Low Density Lipoprotein Receptor-Related Protein 1B (LRP1B) Expression by Genetic and Epigenetic Mechanisms in Esophageal Squamous Cell Carcinoma , 2004, Cancer Research.

[19]  J. Veltman,et al.  Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines. , 2004, Cancer research.

[20]  F. Motoi,et al.  Pancreatic Cancer Registry in Japan: 20 Years of Experience , 2004, Pancreas.

[21]  K. Miyazono,et al.  Smad4-independent regulation of p21/WAF1 by transforming growth factor-β , 2004, Oncogene.

[22]  Yue Zhang,et al.  Regulation of Cell Polarity and Protrusion Formation by Targeting RhoA for Degradation , 2003, Science.

[23]  J. Yokota,et al.  Evaluation of a whole‐genome amplification method based on adaptor‐ligation PCR of randomly sheared genomic DNA , 2003, Genes, chromosomes & cancer.

[24]  Akira Nakagawara,et al.  PPM1D is a potential target for 17q gain in neuroblastoma. , 2003, Cancer research.

[25]  R. DePinho,et al.  Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.

[26]  F. Real,et al.  Genetic profile of 22 pancreatic carcinoma cell lines , 2001, Virchows Archiv.

[27]  Z. Herceg,et al.  Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression , 2001, Nature Genetics.

[28]  J. Inazawa,et al.  Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. , 2001, Cancer research.

[29]  Tomoki Chiba,et al.  Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation* , 2001, The Journal of Biological Chemistry.

[30]  N. Arens,et al.  Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH) , 2000, The Journal of pathology.

[31]  J. Minna,et al.  Enrichment of epithelial cells for molecular studies , 1999, Nature Medicine.

[32]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[33]  M. Cole,et al.  The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.

[34]  B Johansson,et al.  Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer , 1997, Genes, chromosomes & cancer.

[35]  S. Hirohashi,et al.  Modified formalin and methanol fixation methods for molecular biological and morphological analyses , 1997, Pathology international.

[36]  P. Lichter,et al.  Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. , 1996, Cancer research.

[37]  M. Tsao,et al.  Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. , 1996, The American journal of pathology.

[38]  J. Cheng,et al.  Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Bartram,et al.  High frequency of Ki‐ras codon 12 mutations in pancreatic adenocarcinomas , 1989, International journal of cancer.

[40]  T. Sugimura,et al.  Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes. , 1986, Japanese journal of cancer research : Gann.